1/3

FIEO Registered Export Ready

Glimepiride & Metformin Prolonged release Tablets IP

Name: Glimepiride & Metformin Prolonged release Tablets IP
Brand: indiglobal exports
SKU: 8520223
Availability: InStoreOnly

Sold by indiglobal exports · Service Provider , Professional Services, Exporter, Wholesaler · Panchkula, Haryana, India

Price

Price on request

In stock

Minimum order: 1 unit

Export Snapshot

MOQ

1 unit

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for indiglobal exports.

Compliance & Certifications

FIEO Registered

Suitable for

Importers · Distributors · Wholesalers

Panchkula Dispatch on request FIEO member

indiglobal exports

Service Provider , Professional Services, Exporter, Wholesaler · Panchkula, Haryana, India

We are a distinguished merchant trading and export company, specializing in the international supply of premium-quality products across various sectors. Our portfolio includes pharmaceuticals, marketed under a neutral code, as well as millets, mango pulp, compounded animal and livestock feed, and orthopaedic appliances. We take great pride in our meticulous product selection and procurement processes, consistently adhering to the highest standards of quality assurance to ensure the delivery of superior goods to our clients.

Registered address: Chandigarh, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Medical Equipment & Supplies.

View profile All products

Established

2024

Employees

1–10

GST

06EOGPS3248L1ZF

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Apr 2024

Turnover

2500001 - 10000000.

Incorporation Type

On request

Verified Seller IEC Certificate GST Certificate UDYAM Registration Certificate

Product details

What are the specifications of this product?

Overview

Glimepiride & Metformin Prolonged release Tablets IP is a pharmaceutical product indicated for diabetes treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations. Features: Used in the management of diabetes conditions Precise dosage form and active pharmaceutical ingredients Suitable for international pharmaceutical markets Manufactured in GMP-compliant facilities Reliable therapeutic performance Attributes: Category: Diabetes Formulation: Tablet Packaging: Export-grade blister or strip packs Shelf Life: As per regulatory standards Manufacturer: IndiGlobal Exports

Product Description

Product Overview

Glimepiride & Metformin Prolonged release Tablets IP is developed for the effective management of diabetes conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.

Therapeutic Use & Application

This formulation supports the clinical treatment and ongoing care of patients with diabetes indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.

Formulation & Packaging

Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.

Quality & Compliance

The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.

Description provided by indiglobal exports.

Specifications

Category	Diabetes medication
Formulation Type	Tablet
Tablet Type	Prolonged release
Manufacturer	IndiGlobal Exports
Packaging Material	Blister/strip packs
Shelf Life Duration	Defined by exporting country regulatory standards
Distribution Suitability	Hospital, retail, and institutional supply

Use cases

Category	Pharmaceuticals > Anti-Diabetic Drugs > Combination Oral Hypoglycemic Agents
Primary application	Wholesale, distribution, and international sourcing
Brand	indiglobal exports
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 unit
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Glimepiride & Metformin Prolonged release Tablets IP. Answers compiled from verified sellers' commercial terms and platform data.

Q: What is the advantage of the prolonged release formulation in these tablets?

A: The prolonged release formulation ensures a sustained and steady release of Glimepiride and Metformin, maintaining stable blood glucose levels over a longer period and reducing dosing frequency, which improves patient compliance and minimizes side effects.

Q: Are these tablets suitable for export to regulated markets?

A: Yes, the tablets are manufactured in WHO-GMP compliant facilities and meet Indian Pharmacopoeia standards, making them suitable for export to both regulated and semi-regulated pharmaceutical markets.

Q: What packaging options are available for bulk export?

A: Glimepiride & Metformin Prolonged Release Tablets IP are available in export-grade blister or strip packs designed to ensure product stability and facilitate convenient shipping and handling.

Q: Which patient conditions are these tablets indicated for?

A: These tablets are specifically indicated for managing type 2 diabetes mellitus requiring combination therapy of Glimepiride and Metformin for optimal blood glucose control.

Q: How does this product ensure consistent dosage and quality?

A: Each batch undergoes rigorous quality control and testing according to pharmacopoeial standards and is produced in GMP-compliant manufacturing environments to guarantee dosage uniformity and therapeutic efficacy.

Question not answered? Ask sellers directly — typical response within 4 hours.